Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 61.080
Filtrar
2.
Geneva; World Health Organization; 2022-08-03.
en Inglés | WHO IRIS | ID: who-361286
3.
Geneva; World Health Organization; 2022-07-27.
en Inglés | WHO IRIS | ID: who-360983
5.
Geneva; World Health Organization; 2022-07-20.
en Inglés | WHO IRIS | ID: who-360561
7.
Geneva; World Health Organization; 2022-07-13.
en Inglés | WHO IRIS | ID: who-360072
9.
Geneva; World Health Organization; 2022-07-06.
en Inglés | WHO IRIS | ID: who-359148
13.
Ginebra; WHO; rev; June 23, 2022. 22 p. tab..
No convencional en Inglés | BIGG - guías GRADE | ID: biblio-1377570

RESUMEN

A global shortage of an estimated 18 million health workers is anticipated by 2030, a record 130 million people are in need of humanitarian assistance, and there is the global threat of pandemics such as COVID-19. At least 400 million people worldwide lack access to the most essential health services, and every year 100 million people are plunged into poverty because they have to pay for healthcare out of their own pockets. There is, therefore, an urgent need to find innovative strategies that go beyond the conventional health-sector response. These interventions are also relevant for all three areas of the Thirteenth General Programme of Work of the World Health Organization. WHO recommends self-care interventions for every country and economic setting as critical components on the path to reaching universal health coverage (UHC), promoting health, keeping the world safe and serving the vulnerable.


Asunto(s)
Autocuidado , Estilo de Vida Saludable , Promoción de la Salud
14.
No convencional en Inglés | BIGG - guías GRADE | ID: biblio-1373577

RESUMEN

The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with Leishmania infection are highly infectious to sandflies, and an increase in the coinfection rate in an endemic area is likely to increase the effective infective reservoir. Leishmania and HIV reinforce each other, posing clinical and public health problems. In areas where the endemicity of HIV and Leishmania overlap, people living with HIV are more likely to develop visceral leishmaniasis (VL), possibly due to reactivation of a dormant infection or clinical manifestation after primary infection. VL is an AIDS-defining condition, as HIV and Leishmania both suppress the immune system, resulting in more severe VL disease, higher rates of relapse and treatment failure, more toxicity of drugs and higher mortality rates than from either infection in isolation. Patients characteristically have high disseminated parasite loads. VL negatively affects responses to antiretroviral therapy (ART), and co-infected patients are difficult to cure, especially when their CD4 cell count is < 200 cells/mm3, as they typically relapse. Leishmania­HIV coinfection was first reported in the mid-1980s in southern Europe and has since been reported in as many as 45 countries.


Asunto(s)
Humanos , Infecciones por VIH/complicaciones , Quimioterapia Combinada , Leishmaniasis Visceral/etiología , Asia Sudoriental , África Oriental , Antirretrovirales/uso terapéutico , Leishmaniasis Visceral/tratamiento farmacológico , Antihelmínticos/uso terapéutico
15.
No convencional en Inglés | BIGG - guías GRADE | ID: biblio-1373578

RESUMEN

This guideline provides locally adaptable, clear, evidence-informed global recommendations on the fortification of wheat flour with vitamins and minerals as a public health strategy to improve the micronutrient status of populations, which are grounded in gender, equity and human rights approaches with the aim of leaving no one behind. The focus of this document is on the use of this intervention as a public health strategy and not on market-driven fortification of wheat flour or products. This guideline aims to help Member States and their partners to make informed decisions on the appropriate nutrition actions to achieve the 2030 Sustainable Development Goals and the global targets set in the World Health Organization (WHO) comprehensive implementation plan on maternal, infant and young child nutrition. The recommendations in this guideline are intended for a wide audience, including policymakers, expert advisers, and technical and programme staff in ministries and organizations involved in the design, implementation and scaling-up of nutrition actions for public health. The recommendations are particularly relevant to the design and implementation of appropriate food-fortification programmes, as part of a comprehensive food-based strategy for combating micronutrient inadequacies and deficiencies. These recommendations supersede the previous WHO recommendation on the fortification of wheat flour.


Asunto(s)
Humanos , Niño , Adulto , Vitaminas , Nutrición de los Grupos Vulnerables , Alimentos Fortificados , Harina , Anemia/prevención & control , Minerales
16.
Ginebra; WHO; rev; June 27, 2022. 64 p. tab.
No convencional en Inglés | BIGG - guías GRADE | ID: biblio-1377571

RESUMEN

Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa. These guidelines update the recommendations that were first released in 2018 on diagnosing, preventing, and managing cryptococcal disease. In response to important new evidence that became available in 2021, these new guidelines strongly recommend a single high dose of liposomal amphotericin B as part of the preferred induction regimen for the treatment of cryptococcal meningitis in people living with HIV. This simplified regimen - a single high dose of liposomal amphotericin B paired with other standard medicines (flucytosine and fluconazole) - is as effective as the previous WHO standard of care, with the benefits of lower toxicity and fewer monitoring demands. The objective of these guidelines is to provide updated, evidence-informed recommendations for treating adults, adolescents and children living with HIV who have cryptococcal disease. These guidelines are aimed at HIV programme managers, policymakers, national treatment advisory boards, implementing partners and health-care professionals providing care for people living with HIV in resource-limited settings with a high burden of cryptococcal


Asunto(s)
Humanos , Niño , Adolescente , Adulto , Infecciones por VIH/complicaciones , Meningitis Criptocócica/tratamiento farmacológico , Antifúngicos/uso terapéutico , Meningitis Criptocócica/diagnóstico
18.
Geneva; World Health Organization; 2022-06-15.
en Inglés | WHO IRIS | ID: who-356571
19.
Geneva; World Health Organization; 2022-06-08.
en Inglés | WHO IRIS | ID: who-355779
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...